While Pulmonx Corp has overperformed by 6.19%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, LUNG fell by -54.49%, with highs and lows ranging from $9.37 to $2.50, whereas the simple moving average fell by -45.82% in the last 200 days.
On March 10, 2025, D. Boral Capital started tracking Pulmonx Corp (NASDAQ: LUNG) recommending Buy. A report published by Citigroup on December 11, 2024, Downgraded its rating to ‘Neutral’ for LUNG. Lake Street also rated LUNG shares as ‘Buy’, setting a target price of $12 on the company’s shares in an initiating report dated June 04, 2024. Wells Fargo February 23, 2024d the rating to Equal Weight on February 23, 2024, and set its price target from $16 to $14. Craig Hallum initiated its ‘Buy’ rating for LUNG, as published in its report on September 05, 2023. Wells Fargo’s report from February 27, 2023 suggests a price prediction of $15 for LUNG shares, giving the stock a ‘Overweight’ rating. BofA Securities also rated the stock as ‘Underperform’.
Analysis of Pulmonx Corp (LUNG)
Further, the quarter-over-quarter increase in sales is 19.54%, showing a positive trend in the upcoming months.
One of the most important indicators of Pulmonx Corp’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -60.68% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.29, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and LUNG is recording 380.29K average volume. On a monthly basis, the volatility of the stock is set at 8.67%, whereas on a weekly basis, it is put at 13.96%, with a gain of 16.60% over the past seven days. Furthermore, long-term investors anticipate a median target price of $12.50, showing growth from the present price of $3.09, which can serve as yet another indication of whether LUNG is worth investing in or should be passed over.
How Do You Analyze Pulmonx Corp Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 11.95%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 85.56% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
LUNG shares are owned by institutional investors to the tune of 85.56% at present.
